UBS Oncology Impact Fund L.P.
CIK 1691428 · View on SEC EDGAR ↗
Insider
Activist
First SEC filing: Jan. 7, 2021 · Latest: May 12, 2026
Initial ownership (Form 3) 4 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Jan. 7, 2021 | CGEM | Series Seed Convertible Preferred Stock→ Common Stock (1,136,525) | 1,136,525 | Direct |
| Jan. 7, 2021 | CGEM | Series A Convertible Preferred Stock→ Common Stock (3,551,640) | 3,551,640 | Direct |
| Jan. 7, 2021 | CGEM | Series B Convertible Preferred Stock→ Common Stock (2,276,692) | 2,276,692 | Direct |
| Jan. 7, 2021 | CGEM | Series C Convertible Preferred Stock→ Common Stock (649,030) | 649,030 | Direct |